Myasthenia gravis represents chronic autoimmune condition that primarily targets the neuromuscular junction. This junction facilitates the transmission of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system erroneously attacks these receptors, resulting weakness and fatigue in the muscles. The manifest